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EMT Contributes to Ocular cGVHD
Chronic graft-versus-host disease (cGVHD) of the ocular
surface, which may lead to vision loss, is a serious side
effect of bone marrow transplantation. cGVHD is charac-
terized by excessive fibrosis. As epithelial-mesenchymal
transition (EMT) has been implicated in fibrotic diseases,
Ogawa et al (Am J Pathol 2009, 175:2372–2381) ex-
plored the potential role of EMT in ocular cGVHD. They
observed several features of EMT in ocular cGVHD in-
cluding down-regulation of adhesion molecules; up-regu-
lation of SNAIL, a transcription factor that plays a regula-
tory role in EMT; up-regulation of heat shock protein 47,
an EMT marker; and epithelial up-regulation of -smooth
muscle actin, a marker of mesenchymal cells. These
altered cells had disrupted basal epithelia, and altered
collagen bundles were observed in or near altered epi-
thelial cells. These results indicate that EMT may be at
least partially responsible for fibrotic ocular damage in
patients with cGVHD.
Bacterial Lipids Enhance Autoimmunity
Porphyromonas gingivalis, a common oral bacteria in hu-
mans, produces a unique type of lipid, phosphorylated
dihydroceramides (DHCs), which enhances inflammatory
responses. To determine whether these lipids affect au-
toimmunity, Nichols et al (Am J Pathol 2009, 175:2430–
2438) administered phosphorylated DHCs to a mouse
model of multiple sclerosis, experimental autoimmune en-
cephalomyelitis (EAE). The severity of EAE was significantly
enhanced by the addition of phosphorylated DHCs, partic-
ularly by phosphorylated ethanolamine DHCs, in a Toll-like
receptor 2-dependent manner. This response was indepen-
dent of natural killer T cell activation; however, significantly
fewer Foxp3 T cells were present in the spines of EAE
mice with phosphorylated ethanolamine DHC treatment.
These data suggest that phosphorylated DHCs from com-
mon commensal bacteria may enhance autoimmunity, per-
haps by acting as a Toll-like receptor 2 ligand.
Modified pro-NGF May Lead to Symptoms of
Alzheimer Disease
Oxidative stress in the early stages of Alzheimer disease
may modify molecules, resulting in loss or alteration of
their function. A precursor to nerve growth factor (pro-
NGF) is expressed at high levels in Alzheimer disease-
affected individuals, and accumulation of pro-NGF may
lead to neural cell death. Kichev et al (Am J Pathol 2009,
175:2574–2585) showed that pro-NGF was modified by
advanced glycation and lipoxidation end products (AGE/
ALEs) in an Alzheimer disease stage-dependent manner
and that modified pro-NGF blocked processing to mature
NGF and led to neuronal cell death. Furthermore, injec-
tion of modified pro-NGF or pro-NGF derived from human
patients with Alzheimer disease resulted in cognitive and
learning impairment in mice, suggesting that modified
pro-NGF may provide a novel pathogenic pathway for
Alzheimer disease.
Genetic Abnormality in Tumor-Associated
Endothelial Cells
Angiogenesis plays a key role in tumor metastasis. The
endothelial cells that compose tumor-associated blood
vessels were previously thought to be genetically stable,
but recent evidence suggests endothelial cell aneuploidy
in some tumor types. Akino et al (Am J Pathol 2009,
175:2657–2667) hypothesized that endothelial cells as-
sociated with human renal cell carcinoma would have
cytogenetic abnormalities. They found that a portion of
tumor-associated endothelial cells had aneuploidy and
that many of these cells had stem cell-like characteristics
(CD133). Abnormal endothelial cells may therefore con-
tribute to the pathogenesis of metastatic carcinoma.
Wnt Is Pathogenic in Diabetic Retinopathy
Diabetic retinopathy, which results from inflammation in
the eye, is the leading cause of blindness in the working-
age population; however, the mechanisms by which di-
abetes induces this inflammation remain unclear. To de-
termine whether the Wnt signaling pathway, which is
activated under numerous pathological conditions, plays
a role in diabetic retinopathy, Chen et al (Am J Pathol
2009, 175:2676–2685) examined retinal expression lev-
els and nuclear translocation of the Wnt signaling mole-
cule -catenin in human patients with diabetic retinopa-
thy as well as in mouse models. They found high retinal
expression and nuclear translocation of -catenin as well
as increased expression of the Wnt co-receptors RP5/6
(low-density lipoprotein receptor-related proteins 5 and
6) in subjects with diabetic retinopathy. Moreover, inhibi-
tion of Wnt signaling through Dickkopf homolog 1 (DKK1)
ameliorated both generation of reactive oxygen species
and diabetic retinopathy in these models. Wnt therefore
provides a new target for diabetic retinopathy therapy.
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